| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07529080 Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults… |
date change Primary completion pushed: 2029-04 -> 2029-08 |
| 2026-06-10 | NCT07529080 Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults… |
date change Completion pushed: 2029-04 -> 2029-08 |
| 2026-06-10 | NCT07526545 Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer… |
date change Primary completion pushed: 2029-11-01 -> 2030-03-01 |
| 2026-06-10 | NCT07526545 Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer… |
date change Completion pushed: 2029-11-01 -> 2030-03-01 |
| 2026-06-10 | NCT07532525 Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+… |
Recruitment opened |
| 2026-06-10 | NCT07532525 Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+… |
date change Primary completion pushed: 2027-07 -> 2027-08 |
| 2026-06-10 | NCT07532525 Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+… |
date change Completion pushed: 2028-07 -> 2028-08 |
| 2026-05-28 | NCT06914479 Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… |
date change Primary completion moved earlier: 2031-06-01 -> 2031-05 |
| 2026-05-28 | NCT06914479 Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… |
date change Completion moved earlier: 2031-06-01 -> 2031-05 |
| 2026-05-20 | NCT07542405 A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and… |
date change Primary completion pushed: 2028-04 -> 2028-06 |
| 2026-05-20 | NCT07542405 A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and… |
date change Completion pushed: 2028-04 -> 2028-06 |
| 2026-05-15 | NCT05988918 Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-15 | NCT05988918 Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
Enrollment reduced: 66 -> 17 participants |
| 2026-05-15 | NCT05988918 Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
date change Primary completion moved earlier: 2027-04 -> 2026-02-21 |
| 2026-05-15 | NCT05988918 Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
date change Completion moved earlier: 2029-04 -> 2027-08 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07630155 Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05183126 | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With… | Breast Cancer | Recruiting |
| Phase 2 | |||
| NCT05038332 | Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known… | Prostate Cancer | Recruiting |
| NCT04858256 | Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms | T-Cell Neoplasm | Recruiting |
| NCT05894083 | A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at… | Oropharyngeal Cancer | Recruiting |
| NCT07158021 | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT06580054 | Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck | Recruiting |
| NCT05901519 | A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic… | Hepatocellular Carcinoma | Recruiting |
| NCT07443943 | A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in… | Anatomic Stage 0 Breast Cancer AJCC v8 | Recruiting |
| NCT05956041 | Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell… | Cutaneous T Cell Lymphoma | Recruiting |
| NCT04748042 | Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy… | Prostate Cancer | Active, Not Recruiting |
| NCT03787680 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | Prostate Cancer | Active, Not Recruiting |
| NCT04574856 | Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in… | Glioblastoma | Active, Not Recruiting |
| NCT04848337 | Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer | Prostate Cancer Metastatic | Active, Not Recruiting |
| NCT05988918 | Multicenter Trial of ESK981 in Patients With Select Solid Tumors | Pancreatic Adenocarcinoma | Active, Not Recruiting |
| NCT06234748 | Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer | Oropharynx Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06616155 | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT03842696 | Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults… | Hematologic Diseases | Active, Not Recruiting |
| NCT03781986 | APG-115 in Salivary Gland Cancer Trial | Malignant Salivary Gland Cancer | Active, Not Recruiting |
| NCT04194554 | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP… | Prostate Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT05996107 | Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in… | Breast Cancer | Recruiting |
| NCT06914479 | Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… | Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant | Recruiting |
| NCT07532525 | Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+… | Recurrent B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04477200 | Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma | Recurrent Glioblastoma | Active, Not Recruiting |
| Not specified | |||
| NCT05653388 | Metastatic Leiomyosarcoma Biomarker Protocol | Leiomyosarcoma | Recruiting |
| NCT07291414 | A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients | Breast Carcinoma | Recruiting |